Due to health issues, this site is no longer maintained and will be shut down shortly. |
Cocrystal Pharma Inc develops novel medicines for the treatment of human viral diseases. It focuses on the development and commercialization of broad-spectrum antiviral drug candidates that transforms the treatment and prophylaxis of diseases in humans.
$1.87 +0.03 (1.36%)
As of 03/24/2023 16:00:01 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.